Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the Netherlands

References

• Geerts WH, Bergqvist D, Pineo GF, et al. American College of Chest Physicians. Prevention of venous thromboembolism. American college of chest physicians evidence-based clinical practice guidelines. 8th edn. Chest 2008;133(6 Suppl):381S-453S
   PubMed Web of Science ®Google Scholar
• Douketis JD, Eikelboom JW, Quinlan DJ, et al. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002;162:1465-71
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001;358:9-15
   PubMed Web of Science ®Google Scholar
• Ettema HB, Hoppener MR, Büller HR, et al. Tromboprofylaxe in de orthopedische chirurgie: inzichten en onzekerheden. Ned Tijdschr Geneeskd 2003;147:1842-7 [in Dutch]
   PubMedGoogle Scholar
• Hill J, Treasure T; on behalf of the National Clinical Guideline Center for Acute and Chronic Conditions. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ 2010;340:259-260
   Google Scholar
• Biiller HR; Richtlijn diagnostiek, preventie en behandeling van veneuze tromboembolie en secundaire preventie van arteriële trombose. Kwaliteitsinstituut voor de Gezondheidszorg CBO/Nederlands Huisartsen Genootschap. Utrecht 2008. www.cbo.nl/Downloads/492/rl_stol_09.pdf. Accessed August 5, 2010
   Google Scholar
• Struijk-Mulder MC, Ettema HB, Verheyen CC, et al. Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery. J Thromb Haemostas 2010;8:678-83
   PubMedGoogle Scholar
• National Joint Registry for England and Wales 5th Annual Report. 2008; http://www.njrcentre.org.uk/njrcentre/default.aspx. Accessed November 4, 2010
   Google Scholar
• Pharmo Institute. Prevention of thromboembolic disease following knee or hip replacement: ‘burden of illness’. Utrecht: Pharmo Institute, 2008. http://www.pharmo.nl/frames.php?htmlpage=navigatie/reports.htm. Accessed June 8, 2010
   Google Scholar
• Kappelhoff BS. Primaire preventie van veneuze trombo-embolieën na totale heup- of knievervangende operaties: ‘burden of illness’. Pharm Weekbl Wet Platform 2009;4:128-34 [in Dutch]
   Google Scholar
• Anderson FA, Jr. Hirsh J, White K, et al. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee registry. Chest 2003;124(Suppl):349S-56S
   PubMedGoogle Scholar
• Colwell CW, Jr. Pulido P, Hardwick ME, et al. Patient compliance with outpatient prophylaxis: an observational study. Orthopedics 2005;28:143-7
   PubMed Web of Science ®Google Scholar
• Spahn G. Compliance with self-administration of heparin injections in outpatients. Eur J Trauma 2002;28:104-9
   Google Scholar
• Muntz JE, Hultburg R. Safety syringes can reduce the risk of needlestick injuries in venous thromboembolism prophylaxis. J Surg Orthop Adv 2004;13:15-19
   PubMedGoogle Scholar
• Ettema HB, Hoppener MR, Henny CP, et al. Compliance of Dutch orthopedic departments with national guidelines of thromboprophylaxis. A survey of Dutch orthopedic thromboprophylaxis. Acta Orthop 2005;76:99-103
   PubMed Web of Science ®Google Scholar
• Eriksson BI, Dahl OE, Rosencher N, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised double-blind, non-inferiority trial. Lancet 2007;370:949-56
   PubMed Web of Science ®Google Scholar
• Eriksson BI, Dalh OE, Rosencher N, et al. Oral dabigatran etexilate versus subcutaneous enoxaparin for the prevention of venous tromboembolism after total knee replacement: the RE-MODEL randomized trial. J Tromb Haemost 2007;5:2178-85
   PubMed Web of Science ®Google Scholar
• Friedman RJ, Dahl OE, Rosencher N, et al. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthoplasty: a pooled analysis of three trials. Thromb Res 2010;126:175-82
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Acute Care (NCC-AC). Venous thromboembolism: the prevention of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing orthopaedic surgery and other high-risk surgical procedures. London: National Collaborating Centre for Acute Care, 2007. http://www.rcseng.ac.uk/publications/docs/venous_thrombo.html. Accessed November 4, 2010
   Google Scholar
• Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. New Engl J Med 2006;355:809-17
   PubMedGoogle Scholar
• Health Care Insurance Board. Dutch pharmacoeconomic guidelines 2004 [in Dutch]. Amstelveen: Health Care Insurrance Board, 2003. http://www.cvz.nl/resources/FARM_richtlijnen_farmaco-economisch_onderzoek_2006_tcm28-19118.pdf. Accessed August 5, 2010
   Google Scholar
• Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, et al. Guideline for costing research, methods and standardized prices for economic evaluations in health care [in Dutch]. Diemen: Health Care Insurance Board, 2004. http://www.cvz.nl/resources/feo_handleiding-kostenonderzoek2004_tcm28-17013.pdf. Accessed December 21, 2010
   Google Scholar
• Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press, 2008
   Google Scholar
• http://www.fk.cvz.nl/. Accessed August 5, 2010
   Google Scholar
• Nederlandse Orthopaedische Vereniging. Diagnostiek en behandeling van heup- en knieartrose, richtlijn [in Dutch]. Nijmegen: Nederlandse Orthopaedische Vereniging, 2007
   Google Scholar
• National Collaborating Centre for Acute Care (NCC-AC). Venous thromboembolism: the prevention of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing orthopaedic surgery and other high-risk surgical procedures. 2007
   Google Scholar
• http://www.medicijnkosten.nl/. Accessed December 20, 2010
   Google Scholar
• Rice L. Heparin-Induced Thrombocytopenia. Myths and misconceptions. Arch Intern Med 2004;164:1961-4
   PubMedGoogle Scholar
• Oliveira GBF, Crespo EM, Becker RC, et al. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med 2008;168:94-102
   PubMed Web of Science ®Google Scholar
• Ten Berg M, Huisman A, van den Bemt P, et al. Case-finding of possible heparin-induced thrombocytopenia in an academic teaching hospital by linking laboratory and medication data. Pharmacoepidemiol Drug Saf 2007;16:S51
   Google Scholar
• Institute for Medical Technology Assessment. Cost analysis of treatment of adverse events related to treatment of patients with CML. Rotterdam: Institute for Medical Technology Assessment, Erasmus MC, 2007. Report 07.99 (data on file)
   Google Scholar
• Wolowacz SE, Hess N, Brennan VK, et al. Cost-effectiveness of venous thromboembolism prophylaxis in total hip and knee replacement surgery. Current Med Res Opinion 2008;24:2993-3006
   PubMed Web of Science ®Google Scholar
• Hoomans T, van der Roer N, Severens JL, et al. Kosteneffectiviteit van Nieuwe Geneesmiddelen; van belang bij geneesmiddelenvergoeding, maar voor verbetering vatbaa (in Dutch). Nederlands Tijdschrift voor Geneeskunde 2010;154:A958
   PubMedGoogle Scholar
• www.cvz.nl. Accessed December 21, 2010
   Google Scholar
• Boersma C, Broer ACM, Kappelhoff BS, et al. Problemen bij subcutane toediening van laagmoleculairgewichtheparines na totale heup- en knievervangende operaties [in Dutch]. Pharm Weekbl 2010;4:20-4
   Google Scholar
• Dranitsaris G, Jelincic V, Choe Y. Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement. Thromb J 2001;9:3
   Google Scholar
• Smythe MA, Koerber JM, Mattson JC. Identifying the incidence of recognized heparin induced thrombocytopenia in a large tertiary care teaching hospital. Chest 2007;131:1644-9
   PubMed Web of Science ®Google Scholar